AI-generated summary
Forty-five patients with vitiligo were randomly assigned to receive topical tacrolimus with or without monthly CO2 fractional laser treatment. The authors report that the combined group showed better objective and subjective improvement than the tacrolimus-only group after 6 months, with three cases of isomorphic response and one scar.
- Participants
- 45
- Who or what was studied
- Patients with vitiligo
- Limits stated in the abstract
- The abstract describes a preliminary study with a small sample split into subgroups, and it reports that efficacy was limited in patients in the stable stage.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.